Lidocaine hydrochloride monohydrate
SIGMA/L5647 - solid
Synonym: 2-
CAS Number: 6108-05-0
Empirical Formula (Hill Notation): C14H22N2O · HCl · H2O
Molecular Weight: 288.81
EC Number: 200-803-8
MDL Number: MFCD00150329
Linear Formula: C14H22N2O · HCl · H2O
Product Type: Chemical
| color | white |
| form | solid |
| InChI | 1S/C14H22N2O.ClH.H2O/c1-5 |
| InChI key | YECIFGHRMFEPJK-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | Cl[H].[H]O[H].CCN(CC)CC(= |
| solubility | H2O: soluble |
| Application: | Lidocaine hydrochloride monohydrate has been used: • in the preparation of drug composite for the controlled delivery in vitro, evaluated by drug release profile in ultra-high performance liquid chromatography (UPLC) and as a reference standard for fourier transform infrared spectroscopy (FT-IR). • to record dose dependent response of sodium voltage (Nav1.7) channels in the injection-molded polymer device. • For inhibition of glial cells in brain tissue samples. |
| Biochem/physiol Actions: | Na+ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration |
| Biochem/physiol Actions: | Na+ channel blocker; class IB antiarrhythmic. |
| General description: | Lidocaine hydrochloride monohydrate is a commonly used as local anesthetic in topical applications and oral mucosal biopsies. It has a short anesthetic half-life. |
| Packaging: | 15, 100 g in poly bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 36 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |


